Meribank Biotech Co Ltd(TW:4724)
NT$9.12-0.13 (-1.41%)
TW:4724
Meribank Biotech Co Ltd financials statements
NT$9.12
At close:-0.13 (-1.41%)
Meribank Biotech Co Ltd (4724) Financial Statements
Meribank Biotech Co Ltd Financial Overview
Meribank Biotech Co Ltd's market cap is currently NT$887.78M. The company's EPS TTM is NT$-1.44; its P/E ratio is -6.33; Meribank Biotech Co Ltd has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 471.76M | NT$ 366.43M | NT$ 234.34M | NT$ 180.12M | NT$ 163.08M |
| Gross Profit | NT$ 202.18M | NT$ 193.94M | NT$ 138.87M | NT$ 94.77M | NT$ 90.06M |
| Operating Income | NT$ -52.78M | NT$ -86.67M | NT$ -123.15M | NT$ -109.78M | NT$ -97.22M |
| EBITDA | NT$ 102.63M | NT$ -6.83M | NT$ -92.56M | NT$ -64.66M | NT$ -68.60M |
| Net Income | NT$ -81.47M | NT$ -94.71M | NT$ -125.35M | NT$ -102.13M | NT$ -99.19M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 229.34M | NT$ 165.09M | NT$ 399.46M | NT$ 207.86M | NT$ 286.25M |
| Total Assets | NT$ 2.88B | NT$ 2.68B | NT$ 1.06B | NT$ 846.33M | NT$ 947.32M |
| Total Debt | NT$ 1.13B | NT$ 942.84M | NT$ 34.04M | NT$ 45.83M | NT$ 52.97M |
| Net Debt | NT$ 1.03B | NT$ 777.75M | NT$ -365.42M | NT$ -39.33M | NT$ -139.18M |
| Total Liabilities | NT$ 1.62B | NT$ 1.46B | NT$ 390.81M | NT$ 372.53M | NT$ 361.27M |
| Stockholders' Equity | NT$ 1.25B | NT$ 1.21B | NT$ 661.73M | NT$ 471.20M | NT$ 586.05M |
| Cash Flow | |||||
| Free Cash Flow | NT$ 84.57M | NT$ -382.28M | NT$ -36.38M | NT$ -45.58M | NT$ -30.52M |
| Operating Cash Flow | NT$ 89.45M | NT$ -38.09M | NT$ -29.70M | NT$ -41.33M | NT$ -23.00M |
| Investing Cash Flow | NT$ -170.08M | NT$ -362.46M | NT$ 48.15M | NT$ -45.01M | NT$ -118.07M |
| Financing Cash Flow | NT$ 13.71M | NT$ 166.17M | NT$ 295.85M | NT$ -20.66M | NT$ 281.82M |
Currency in TWD

